Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1

Autophagy

Volumn 8, Issue 1, 2012, Pages 109-121

  Zhan, ZhenZhen ^a   Li, Qun ^a   Wu, Ping ^a   Ye, Yan ^a   Tseng, Hsin Yi ^b   Zhang, Linjie ^a   Zhang, Xu Dong ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Apoptosis; Autophagy; Gastric cancer cells; HMGB1; Mcl 1; Vincristine

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN MCL 1; VINCRISTINE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 84863013575     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.8.1.18319     Document Type: Article

References (56)

1. Rabinowitz JD, White E. Autophagy and metabolism. Science 2010; 330:1344-8; PMID:21127245; http://dx.doi.org/10.1126/science.1193497
2. Kroemer G, Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5:886-97; PMID:16239905; http://dx.doi.org/10.1038/nrc1738
3. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-34; PMID: 16148885; http://dx.doi.org/10.1038/nrc1692
4. Stipanuk MH. Macroautophagy and its role in nutrient homeostasis. Nutr Rev 2009; 67:677-89; PMID: 19941614; http://dx.doi.org/10.1111/j.1753-4887.2009. 00252.x
5. Czaja MJ. Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology 2011; 140:1895-908; PMID:21530520; http://dx.doi.org/10.1053/j.gastro.2011.04.038
6. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010; 13:805-11; PMID:20581817; http://dx.doi.org/10.1038/nn.2575
7. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010; 90:1383-435; PMID: 20959619; http://dx.doi.org/10.1152/physrev.00030.2009
8. Eng CH, Abraham RT. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming. Oncogene 2011. In press. PMID:21666712; http://dx.doi.org/10.1038/onc.2011.220
9. Jin S, White E. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 2008; 4:563-6; PMID:18326941
10. Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res 2010; 70:3431-4; PMID:20424122; http://dx.doi.org/10. 1158/0008-5472.CAN-09-4027
11. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005; 115:2679-88; PMID: 16200202; http://dx.doi.org/10.1172/JCI26390
12. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16:663-9; PMID:15530778; http://dx.doi.org/10.1016/j.ceb.2004.09.011
13. Schmitt CA, Lowe SW. Apoptosis is critical for drug response in vivo. Drug Resist Updat 2001; 4:132-4; PMID: 11512522; http://dx.doi.org/10.1054/drup. 2001.0188
14. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55:178-94; PMID:15890640; http://dx.doi.org/10. 3322/canjclin.55.3.178
15. Hersey P, Zhang XD. Overcoming resistance of cancer cells to apoptosis. J Cell Physiol 2003; 196:9-18; PMID:12767037; http://dx.doi.org/10.1002/jcp.10256
16. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26:1324-37; PMID:17322918; http://dx.doi.org/10.1038/sj. onc.1210220
17. Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471:110-4; PMID:21368834; http://dx.doi.org/10.1038/nature09779
18. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471:104-9; PMID:21368833; http://dx.doi.org/10.1038/ nature09732
19. Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011; 8:528-39; PMID:21587219; http://dx.doi.org/10.1038/nrclinonc.2011.71
20. Li H, Wang P, Sun Q, Ding WX, Yin XM, Sobol RW, et al. Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res 2011; 71:3625-34; PMID:21444671; http://dx.doi.org/10.1158/0008-5472.CAN-10-4475
21. Müller S, Scaffidi P, Degryse B, Bonaldi T, Ronfani L, Agresti A, et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 2001; 20:4337-40; PMID:11500360; http://dx.doi.org/10.1093/emboj/20.16.4337
22. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5:331-42; PMID: 15803152; http://dx.doi.org/10.1038/nri1594
23. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010; 29:5299-310; PMID:20622903; http://dx.doi.org/10.1038/onc.2010.261
24. Yang H, Wang H, Tracey KJ. HMG-1 rediscovered as a cytokine. Shock 2001; 15:247-53; PMID:11303722; http://dx.doi.org/10.1097/00024382-200115040-00001
25. Tang D, Kang R, Zeh HJ, 3rd, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 2011; 14:1315-35; PMID:20969478; http://dx.doi.org/10.1089/ars.2010.3356
26. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28:367-88; PMID:20192808; http://dx.doi.org/10.1146/annurev.immunol.021908.132603
27. van ZoelenMA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in highmobility group box 1-induced inflammation in vivo. Shock 2009; 31:280-4; PMID:19218854; http://dx.doi.org/10.1097/SHK.0b013e318186262d
28. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26:174-9; PMID:16878026; http://dx.doi.org/10.1097/01.shk.0000225404.51320.82
29. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011; 25:23-31; PMID:20927132; http://dx.doi.org/10.1038/leu.2010.225
30. Candolfi M, Yagiz K, Foulad D, Alzadeh GE, Tesarfreund M, Muhammad AK, et al. Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity. Clin Cancer Res 2009; 15:4401-14; PMID:19570774; http://dx.doi.org/10.1158/1078-0432.CCR-09-0155
31. Tafani M, Schito L, Pellegrini L, Villanova L, Marfe G, Anwar T, et al. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis 2011; 32:1167-75; PMID:21642357; http://dx.doi.org/10.1093/carcin/bgr101
32. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003; 284:C870-9; PMID:12620891
33. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151-75; PMID: 18188003
34. Wallington-Beddoe CT, Hewson J, Bradstock KF, Bendall LJ. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy 2011; 7:707-15; PMID:21460633; http://dx.doi.org/10.4161/auto.7.7.15154
35. Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Clin Cancer Res 2006; 12:1355-64; PMID:16489094; http://dx.doi.org/10.1158/1078-0432.CCR-05-2084
36. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190:881-92; PMID: 20819940; http://dx.doi.org/10.1083/jcb.200911078
37. Thorburn J, Frankel AE, Thorburn A. Regulation of HMGB1 release by autophagy. Autophagy 2009; 5:247-9; PMID:19098461; http://dx.doi.org/10.4161/ auto.5.2.7552
38. Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, et al. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 2008; 15:3-12; PMID:18007663; http://dx.doi.org/10.1038/sj.cdd.4402269
39. Kang R, Livesey KM, Zeh HJ, 3rd, Lotze MT, Tang D. HMGB1 as an autophagy sensor in oxidative stress. Autophagy 2011; 7:904-6; PMID:21487246; http://dx.doi.org/10.4161/auto.7.8.15704
40. Abdulghani J, El-Deiry WS. TRAIL receptor signaling and therapeutics. Expert Opin Ther Targets 2010; 14:1091-108; PMID:20819019; http://dx.doi.org/10. 1517/14728222.2010.519701
41. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F, et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17:1475-86; PMID:12783855; http://dx.doi.org/10. 1101/gad.1093903
42. Warr MR, Shore GC. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 2008; 8:138-47; PMID:18336294; http://dx.doi.org/10.2174/ 156652408783769580
43. Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumor cell survival. Nature 2010; 463:103-7; PMID:20023629; http://dx.doi.org/10.1038/nature08646
44. Zhong Q, Gao W, Du F, Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121:1085-95; PMID:15989957; http://dx.doi.org/10.1016/j.cell.2005.06.009
45. Iglesias-Serret D, Piqué M, Gil J, Pons G, López JM. Transcriptional and translational control of Mcl-1 during apoptosis. Arch Biochem Biophys 2003; 417: 141-52; PMID:12941295; http://dx.doi.org/10.1016/ S0003-9861(03)00345-X
46. Piret JP, Minet E, Cosse JP, Ninane N, Debacq C, Raes M, et al. Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J Biol Chem 2005; 280:9336-44; PMID:15611089; http://dx.doi.org/10.1074/jbc. M411858200
47. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107:351-62; PMID:11160159; http://dx.doi.org/10.1172/JCI9940
48. Dong L, Jiang CC, Thorne RF, Croft A, Yang F, Liu H, et al. Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. Oncogene 2011; 30:3716-26; PMID:21423203; http://dx.doi.org/10.1038/ onc.2011.87
49. Pickering BM, de Mel S, Lee M, Howell M, Habens F, Dallman CL, et al. Pharmacological inhibitors of NFkappaB accelerate apoptosis in chronic lymphocytic leukaemia cells. Oncogene 2007; 26:1166-77; PMID: 16924235; http://dx.doi.org/10.1038/sj.onc.1209897
50. Wang YF, Jiang CC, Kiejda KA, Gillespie S, Zhang XD, Hersey P. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin Cancer Res 2007; 13:4934-42; PMID: 17652623; http://dx.doi.org/10.1158/1078-0432.CCR-07- 0665
51. Loos B, Genade S, Ellis B, Lochner A, Engelbrecht AM. At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res 2011; 317:1437-53; PMID: 21420401; http://dx.doi.org/10.1016/j.yexcr.2011.03.011
52. Ruela-de-Sousa RR, Fuhler GM, Blom N, Ferreira CV, Aoyama H, Peppelenbosch MP. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis 2010; 1:e19; PMID:21364620; http://dx.doi.org/10.1038/cddis.2009.18
53. Crazzolara R, Cisterne A, Thien M, Hewson J, Baraz R, Bradstock KF, et al. Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia. Blood 2009; 113:3297-306; PMID:19196656; http://dx.doi.org/10.1182/blood-2008-02-137752
54. Zhang LJ, Chen S, Wu P, Hu CS, Thorne RF, Luo CM, et al. Inhibition of MEK blocks GRP78 up-regulation and enhances apoptosis induced by ER stress in gastric cancer cells. Cancer Lett 2009; 274:40-6; PMID:18829155; http://dx.doi.org/10.1016/j.canlet.2008.08.030
55. Mhaidat NM, Zhang XD, Jiang CC, Hersey P. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin Cancer Res 2007; 13:1308-14; PMID:17317842; http://dx.doi.org/10.1158/1078-0432.CCR-06-2216
56. Yang F, Tay KH, Dong L, Thorne RF, Jiang CC, Yang E, et al. Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells. Cell Death Differ 2010; 17:1354-67; PMID:20300110; http://dx.doi.org/10.1038/cdd. 2010.29